Department of TB and Chest Diseases
شامل ہونے کے منصوبے
Dept. data last updated on :10/01/2026
A prospective , randomizes, double blind,Placebo controlled, Phase III , Multicenter study to evaluate Immunigenicity and safety of Recombinant Hepatitis E Vaccine in healthy adults and Adolescents
Study code- URI/HEV/CT-01/21 Version 01/24 Feb 2021
Sponser- Urihk Pharmaceutical private limited
PI- Dr Lubna Zafar
Co-PI - Prof Mohammad Shameem
Co-PI- Dr Nafees Ahmad Khan
Chairman and Professor